1. Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

   • Samuel A. Bobholz
   • Alisha Hoefs
   • Peter S. LaViolette

   Research Open access 19 February 2024 Pages: 233 - 241

   

2. Correction to: Radio-pathomic maps of glioblastoma identify phenotypes of non-enhancing tumor infiltration associated with bevacizumab treatment response

   • Samuel A. Bobholz
   • Alisha Hoefs
   • Peter S. LaViolette

   Correction Open access 18 March 2024 Pages: 243 - 243

3. Repeat surgery of recurrent glioma for molecularly informed treatment in the age of precision oncology: A risk–benefit analysis

   • Obada T. Alhalabi
   • Philip Dao Trong
   • Christine Jungk

   Research Open access 09 February 2024 Pages: 245 - 255

   

4. The role of spine stereotactic radiosurgery for patients with breast cancer metastases

   • Suchet Taori
   • Samuel Adida
   • Peter C. Gerszten

   Research 14 February 2024 Pages: 257 - 266

   

5. Repeated surgical resections for management of high-grade glioma and its impact on quality of life

   • Jun Min Koay
   • Loizos Michaelides
   • David S. Sabsevitz

   Research 13 February 2024 Pages: 267 - 273

   

6. Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy

   • Dana Shor
   • Alexander V. Louie
   • Hanbo Chen

   Research 25 March 2024 Pages: 275 - 283

   

7. Prognostic factors analysis of diffuse midline glioma

   • Jing Jiang
   • Wen-bin Li
   • Shao-wen Xiao

   Research Open access 21 February 2024 Pages: 285 - 292

   

8. Correction to: Prognostic factors analysis of diffuse midline glioma

   • Jing Jiang
   • Wen-bin Li
   • Shao-wen Xiao

   Correction Open access 15 March 2024 Pages: 293 - 293

9. Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center

   • Melek Tugce Yilmaz
   • Alper Kahvecioglu
   • Faruk Zorlu

   Research Open access 22 February 2024 Pages: 295 - 303

   

10. The diagnostic efficiency of integration of 2HG MRS and IVIM versus individual parameters for predicting IDH mutation status in gliomas in clinical scenarios: A retrospective study

    • Meimei Yu
    • Ying Ge
    • Huicong Shen

    Research 29 February 2024 Pages: 305 - 313

    

11. Diverse learners: learning disabilities and quality of life following mind–body and health education interventions for adults with neurofibromatosis

    • Millan R. Kanaya
    • Jonathan Greenberg
    • Ana-Maria Vranceanu

    Research 27 February 2024 Pages: 315 - 322

    

12. Palliative care for in-patient malignant glioma patients in Germany

    • Larissa Fink
    • Birgitt van Oorschot
    • Marcel A. Kamp

    Research Open access 20 March 2024 Pages: 323 - 338

    

13. Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma

    • Phioanh Leia Nghiemphu
    • Jeremie Vitte
    • Marco Giovannini

    Case Study Open access 19 February 2024 Pages: 339 - 348

    

14. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

    • James L. Rogers
    • Thomas Wall
    • Marta Penas-Prado

    Case Study Open access 01 March 2024 Pages: 349 - 359

15. Comment: Additional factors affecting cognitive function in low grade glioma patients

    • Polina Angelova
    • Maria Gicheva

    Correspondence 13 February 2024 Pages: 361 - 362

16. Letter to the editor: Dexamethasone and overall survival and progression free survival in patients with newly diagnosed glioblastoma: a meta-analysis

    • Peter G. Zaki
    • Sanjeev Herr
    • Matthew J. Shepard

    Correspondence 22 March 2024 Pages: 363 - 364

17. Harnessing imaging biomarkers for glioblastoma metastasis diagnosis: a correspondence

    • Mohamed Jalloh
    • Samuel Berchi Kankam

    Correspondence 23 February 2024 Pages: 365 - 367

18. Correction to: Targeted immunotherapy for glioblastoma involving whole tumor-derived autologous cells in the upfront setting after craniotomy

    • Carrie E. Andrews
    • Jenny Zilberberg
    • David W. Andrews

    Correction Open access 22 March 2024 Pages: 369 - 369

19. Correction to: Focused ultrasound combined with radiotherapy for malignant brain tumor: a preclinical and clinical study

    • Ko-Ting Chen
    • Chiung-Yin Huang
    • Kuo-Chen Wei

    Correction 10 April 2024 Pages: 371 - 371